Abstract:Background Breast cancer is one of the most common cancers and the leading cause of death from cancer among women worldwide. The genetic predisposition to breast cancer may be associated with a mutation in particular genes such as gene BRCA1/2. Patients who carry a germline pathogenic mutation in BRCA1/2 genes have a significantly increased risk of developing breast cancer and might benefit from targeted therapy. However, genetic testing is time consuming and costly. This study aims to predict the risk of gBRCA mutation by using the whole-slide pathology features of breast cancer H&E stains and the patients’ gBRCA mutation status. Methods In this study, we trained a deep convolutional neural network (CNN) of ResNet on whole-slide images (WSIs) to predict the gBRCA mutation in breast cancer. Since the dimensions are too large for slide-based training, we divided WSI into smaller tiles with the original resolution. The tile-based classification was then combined by adding the positive classification result to generate the combined slide-based accuracy. Models were trained based on the annotated tumor location and gBRCA mutation status labeled by a designated breast cancer pathologist. Four models were trained on tiles cropped at 5×, 10×, 20×, and 40× magnification, assuming that low magnification and high magnification may provide different levels of information for classification. Results A trained model was validated through an external dataset that contains 17 mutants and 47 wilds. In the external validation dataset, AUCs (95% CI) of DL models that used 40×, 20×, 10×, and 5× magnification tiles among all cases were 0.766 (0.763–0.769), 0.763 (0.758–0.769), 0.750 (0.738–0.761), and 0.551 (0.526–0.575), respectively, while the corresponding magnification slides among all cases were 0.774 (0.642–0.905), 0.804 (0.676–0.931), 0.828 (0.691–0.966), and 0.635 (0.471–0.798), respectively. The study also identified the influence of histological grade to the accuracy of the prediction. Conclusion In this paper, the combination of pathology and molecular omics was used to establish the gBRCA mutation risk prediction model, revealing the correlation between the whole-slide histopathological images and gRCA mutation risk. The results indicated that the prediction accuracy is likely to improve as the training data expand. The findings demonstrated that deep CNNs could be used to assist pathologists in the detection of gene mutation in breast cancer.

Predict Ki-67 Positive Cells in H&E-Stained Images Using Deep Learning Independently from IHC-Stained Images

A deep learning model to predict Ki-67 positivity in oral squamous cell carcinoma

Prediction of PD-L1 tumor positive score in lung squamous cell carcinoma with H&E staining whole slide images and deep learning

Transformation from hematoxylin-and-eosin staining to Ki-67 immunohistochemistry digital staining images using deep learning: experimental validation on the labeling index

A Deep Learning Method for Automatic Evaluation of Diagnostic Information from Multi-Stained Histopathological Images

DeepSDCS: Dissecting cancer proliferation heterogeneity in Ki67 digital whole slide images

[Intelligent Prediction of HER2 Status Based on Breast Histopathology].

A Domain Adaptive and Label-efficient Deep Learning Method for Ki-67 Scoring in Infiltrative Breast Ductal Carcinoma Cells.

Predicting Ki67, ER, PR, and HER2 Statuses from H&E-stained Breast Cancer Images

Automated quantitative analysis of Ki-67 staining and HE images recognition and registration based on whole tissue sections in breast carcinoma

Deep-Learning-Based Approach in Cancer-Region Assessment from HER2-SISH Breast Histopathology Whole Slide Images

Immunohistochemical HER2 Recognition and Analysis of Breast Cancer Based on Deep Learning

Deep Learning-Based H-Score Quantification of Immunohistochemistry-Stained Images

Prediction of BRCA Gene Mutation in Breast Cancer Based on Deep Learning and Histopathology Images

HER2 and FISH Status Prediction in Breast Biopsy H&E-Stained Images Using Deep Learning

Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning

Computer-aided Detection of Squamous Carcinoma of the Cervix in Whole Slide Images

AI-Powered Segmentation of Invasive Carcinoma Regions in Breast Cancer Immunohistochemical Whole-Slide Images

Interpretable Classification from Skin Cancer Histology Slides Using Deep Learning: A Retrospective Multicenter Study

Deep learning-based image analysis predicts PD-L1 status from H&E-stained histopathology images in breast cancer

Prediction of Epidermal Growth Factor Receptor Mutation Subtypes in Non-Small Cell Lung Cancer From Hematoxylin and Eosin-Stained Slides Using Deep Learning